Cocrystal Pharma (COCP) EBITDA Margin Growth (1y) (2011 - 2020)
Cocrystal Pharma (COCP) EBITDA Margin Growth (1y) (2011 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1.16 Mn |
| Sep 30, 2020 | -18,651.00 |
| Jun 30, 2020 | -36,092.00 |
| Mar 31, 2020 | -48,204.00 |
| Jun 30, 2013 | -4,319.00 |
| Mar 31, 2013 | -3,342.00 |
| Dec 31, 2012 | -4,277.00 |
| Sep 30, 2012 | 6,330.00 |
| Jun 30, 2012 | 2,323.00 |
| Mar 31, 2012 | -2,053.00 |
| Dec 31, 2011 | -310.00 |
| Sep 30, 2011 | -6,277.00 |
| Jun 30, 2011 | -2,402.00 |